AR and adenocarcinoma: This profound phenotypic shift, as a result of selection pressure from ADT or potent antiandrogens, from tumors with histological features of adenocarcinoma that express AR to AR-negative neuroendocrine prostate tumors has been termed lineage plasticity[98].